A Fast-Acting, Evidence-Based Option for Treatment-Resistant Mental Health Conditions
Ketamine is an FDA-approved medication originally used for anesthesia. At low, controlled doses, ketamine has been shown to rapidly improve symptoms of treatment-resistant depression, PTSD, anxiety disorders, and acute suicidal ideation.
Supported by NIH/NIMH clinical trials, JAMA Psychiatry, American Journal of Psychiatry, and VA/DoD
studies.
